Taiwan’s CDIB Private Equity has teamed up with China’s state-owned Govtor Capital to create a RMB2 billion ($320 million) private equity fund.
Greater China | 26 May 2014 |
Next Capital has agreed to exit its stake in Fuji Medical Instruments (Fujiiryoki), a Japanese manufacturer of massage chairs and other health-related products, to Asahi Holdings for JPY7.8 billion ($76.7 million).
North Asia | 20 May 2014 |
Taiwan’s National Development Fund has committed NT$1.15 billion ($38 million) to local polysilicon maker Powertec Energy Corporation and a biomedical-focused fund owned by China Development Industrial Bank (CDIB).
Greater China | 19 May 2014 |
US biotech firm Cancer Genetics has acquired India's BioServe Biotechnologies for around $1.9 million, paving an exit for early-stage investor Ventureast.
South Asia | 16 May 2014 |
GIC Private has agreed to invest PHP3.7 billion ($84.5 million) for a 14.4% stake in hospital business of Philippines-based conglomerate Metro Pacific Investments Corp.
Expansion | 16 May 2014 |
The Indian government has given KKR the go-ahead to acquire stakes in Gland Pharma and its affiliate Gland Celcus Bio Chemicals in a deal said to be worth around $230 million.
South Asia | 14 May 2014 |
Fosun Group has highlighted the China growth potential of private equity-owned Australian hospital operator Healthscope, prompting speculation it might bid for the asset.
Greater China | 13 May 2014 |
Xeraya Capital, a life sciences investor controlled by Khazanah Nasional, and PE fund JP Asia Prime Capital have invested S$16 million ($12.8 million) in PrIME Biologics, a subsidiary of NuSep that specializes in therapeutic plasma products.
Healthcare | 12 May 2014 |
Indian hospital chain Aster DM Healthcare is said to be raising $65 million from existing backers Olympus Capital Asia and India Value Fund Advisors (IVFA).
Healthcare | 07 May 2014 |
The Asian Development Bank (ADB) is to commit up to $60 million to Orbimed Advisors' second Asian healthcare fund - OrbiMed Asia Partners II.
South Asia | 05 May 2014 |
Shanghai-listed Kunming Pharmaceutical Corp. has partnered with a direct investment arm of Ping An Securities to set up a healthcare-focused M&A fund, with a target of RMB500 million ($80 million).
Greater China | 29 Apr 2014 |
New Horizon Capital has led a $70 million Series C round of funding for Arrail Dental Clinic, a Beijing-based dental service provider.
Greater China | 22 Apr 2014 |
A consortium comprising TPG Capital and Fosun Industrial has agreed to privatize NASDAQ-listed Chinese healthcare provider Chindex International in a deal worth $461 million, after raising its offer to head off competition from a rival financial bidder....
Buyouts | 22 Apr 2014 |
China-focused PE firm Hony Capital is tracking investment opportunities in state-owned manufacturing and healthcare companies as the government seeks to further restructure its assets.
Greater China | 15 Apr 2014 |
Updating your subscription status
As investor's confidence in the domestic economy is restored, Taiwan's private equity sector players are anticipating a long-awaited upswing in activity, especially with a more transparent and open regulatory environment to revive growth. Positive signals from the government include the new M&A regulation, which will add on protection of minority shareholders upon its launch. The National Development Fund has also injected billions of cash into local funds in an effort to support industrial innovation.
20 November 2014, The Westin Hotel, Taipei
With the empathic and historic victory of Narendra Modi at the recent elections in India, the market confidence has improved significantly. Until recently, India was mentioned in financial markets only in a negative light given the enormous potential and lack of delivery. Difficulties in exiting, arbitrary taxation and poor governance are just some of the chronic problems deterring investors.
Discover what repercussions the latest political developments will have on the private equity industry, the outlook for the next wave of fundraising, where GPs expect to source exits and the best way forward for existing and potential investors.
2-3 December 2014, Taj Lands End Hotel, Mumbai